BIT’s 17th Annual International Congress of
Drug Discovery Science & Technology 2019
Theme: The Disruptive, Integrate, Innovation and Development
Time: November 15-17, 2019
Place: Nanjing, China |
Important Activities |
Scientific Program |
|||||||||
Scientific Program |
||
Stream 6 Project Matchmaking |
||
Time |
Speeches and Speakers |
|
Chair |
Dr. Zaihui Zhang, CSO and VP R & D, Signalchem Lifesciences Corp., Canada |
|
15:30-15:35 |
Chair's Introduction |
|
15:35-15:45 |
Title: Pulsatilla Saponins Synergistically Enhance Anticancer Activity of Chemotherapeutic Agents Through Inhibiting Autophagy |
|
15:45-15:55 |
Title: The Efficacy of Targeting Peptides for MRI Analysis and Chemotherapy for Nasopharyngeal Carcinoma, Breast and Other Cancers |
|
15:55-16:05 |
Title: mABs Targeting Cytokine Receptors |
|
16:05-16:15 |
Title: AI Based Psychological Care Application Devices |
|
16:15-16:25 |
Title: Novel Anti-inflammatory Phytomedicines and Anti-cancer Vaccines |
|
16:25-16:35 |
Title: Partnership in Sublingual GLP 1 Projects in China |
|
16:35-16:45 |
Title: SLC-391 – A Potent and Selective Axl Inhibitor for Cancer Therapy |
|
16:45-16:55 |
Title: Biomedical Innovation and Industrialization Project |
Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2003-2019 BIT Group Global Ltd.